Navigation Links
Approved Lymphoma Drug Shows Promise in Early Tests Against Bone Cancer
Date:11/5/2009

ROCHESTER, N.Y., Nov. 5 /PRNewswire-USNewswire/ -- A drug already approved for the treatment of lymphoma may also slow the growth of the most deadly bone cancer in children and teens, according to an early-stage study published online today in the International Journal of Cancer. The study drug, Bortezomib, was found to be effective against bone cancer in human cancer cell studies and in mice. While key experiments were in animals, the cancer studied closely resembled the human form and the drug has already been proven to be safe in human patients.

In the current study, researchers sought to use Bortezomib (Velcade(R)) against osteosarcoma, an aggressive cancer that starts in bone, spreads quickly and responds poorly to current chemotherapies. The drug, a proteasome inhibitor developed by Millennium Pharmaceuticals and Johnson & Johnson, was approved by the FDA for the treatment of a rare, aggressive form of non-Hodgkin's lymphoma in 2006 and for multiple myeloma in 2008.

"Our most clinically relevant finding is that a drug already proven safe and effective in treating the most common cancers of the blood may be equally effective in suppressing bone cancer," said Roman Eliseev, M.D., Ph.D., research assistant professor within the Center for Musculoskeletal Research and the James P. Wilmot Cancer Center, both within the University of Rochester Medical Center. "Bortezomib caused osteosarcoma cells to self destruct, and prevented their spread. While further studies are needed, our findings suggest that this drug may represent a new treatment option for a devastating disease and an effective complement to current chemotherapies."

Reason to Hope

Eliseev's lab and others have shown that a protein complex called
'/>"/>

SOURCE University of Rochester Medical Center
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Solos Endoscopy, Inc.s FDA Approved MammoView(TM) Product Line to Obtain CE Mark
2. Minimally Invasive Device Approved to Treat Liver Cancer, Fibroids, Tumors, and Bleeding
3. FDA Acts to Halt Marketing of Unapproved Codeine Sulfate Tablets
4. Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
5. CSL Behring Announces FDA Approval of Berinert(R), First and Only Therapy Approved for the Treatment of Acute Abdominal and Facial Attacks of Hereditary Angioedema in U.S.
6. United States Patent Office Allows Claims Covering the Approved Administration of Kuvan with Food
7. ASMANEX(R) (Mometasone Furoate Dry Powder Inhaler) Now Approved in Japan for the Treatment of Bronchial Asthma in Adult Patients
8. Glivec(R) is the First Adjuvant Treatment Approved in the UK to Delay Return of Gastrointestinal Cancer After Surgery
9. Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib
10. CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency
11. Pioneering Diamyd(R) Study to Prevent Childhood Diabetes Approved
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 10, 2014  Decision Resources Group finds that ... (ID) specialists are willing to prescribe Durata,s Dalvance ... use as OPAT, approximately two-thirds of the respondents ... their hospital inpatients. However, our findings indicate that ... initiated on OPAT following hospital discharge, and most ...
(Date:7/10/2014)... , July 10, 2014 CVS Caremark Corporation (NYSE: ... directors has approved a quarterly dividend of $0.275 (27.5 cents) ... payable on August 1, 2014, to holders of record on ... CVS Caremark is dedicated to helping people on their ... in the United States . Through the ...
(Date:1/15/2014)... MILTON, N.Y. , Jan. 15, 2014 Sono-Tek Corporation ... three months ended November 30, 2013, compared to sales of ... or 20%. Once again, this quarter has also shown growth ... in the first quarter of this fiscal year. Markets that ...
Breaking Medicine Technology:Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4
... functional,MRI (fMRI) have determined that the circuitry in ... is dysfunctional in patients suffering from,stress-related psychiatric disorders. ... the annual meeting of the Radiological Society of ... "For patients with major depression and other ...
... LENEXA, Kan., Dec. 2 IBT Laboratories, a leading ... allergy assays, announced that it has launched two ... immune systems may be compromised due to a primary ... immuno-suppressing drugs to prevent rejection of a transplant. The ...
Cached Medicine Technology:Stress-Related Disorders Affect Brain's Processing of Memory 2Stress-Related Disorders Affect Brain's Processing of Memory 3IBT Laboratories Expands its Menu of Tests for Immune Deficiency 2
(Date:7/12/2014)... By Dennis Thompson ... -- There,s no way to guarantee that a surgical technique ... tiny incisions won,t increase the risk of spreading cancer to ... Friday. The advisory panel to the Food and Drug ... -- called laparoscopic power morcellation -- should sign a written ...
(Date:7/12/2014)... 2014 In this cognitive ... assessment and training’ is defined as solution ... or enhance cognitive functions. These solutions are ... dementia screening, clinical trials, driver’s safety, rehabilitation, ... assessment, brain training, and employers’ assessment and ...
(Date:7/12/2014)... July 12, 2014 The Security Analytics ... 2013 to $3,376.6 million by 2019, at an expected ... 2019. The challenges to counter the increasing number of ... of outdated cyber defense systems in organizations are enormous. ... and remodeling their existing architecture to develop better and ...
(Date:7/12/2014)... New York (PRWEB) July 12, 2014 ... damage allegations continue to move forward in the ... Eastern District of Pennsylvania, Bernstein Liebhard LLP reports. ... U.S. District Judge Lawrence F. Stengel has ordered ... other things, Judge Stengel found that the witness’s ...
(Date:7/12/2014)... News) -- If you make exercise fun, you,ll eat less ... 56 adults were led on a 1.4-mile walk and were ... scenic walk. The participants were given lunch after the walk, ... ate 35 percent more chocolate pudding for dessert than those ... another experiment, 46 adults were given mid-afternoon snacks after their ...
Breaking Medicine News(10 mins):Health News:FDA Advisers Weigh Risks of Procedure for Removal of Uterine Fibroids 2Health News:FDA Advisers Weigh Risks of Procedure for Removal of Uterine Fibroids 3Health News:Global Cognitive Assessment & Training Market: 27.3% CAGR to 2018 Says a New Research Report Available at LifeScienceIndustryResearch.com 2Health News:Global Cognitive Assessment & Training Market: 27.3% CAGR to 2018 Says a New Research Report Available at LifeScienceIndustryResearch.com 3Health News:Global Cognitive Assessment & Training Market: 27.3% CAGR to 2018 Says a New Research Report Available at LifeScienceIndustryResearch.com 4Health News:Global Cognitive Assessment & Training Market: 27.3% CAGR to 2018 Says a New Research Report Available at LifeScienceIndustryResearch.com 5Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 4Health News:Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports 2Health News:Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports 3Health News:Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports 4Health News:Make Exercise Fun, Eat Less Afterwards 2
... Hospital among top 5% of safest,hospitals in the U.S., ... Center today announced that it has again been named ... patient safety based on a study by,HealthGrades(R), the nation,s ... HealthGrades has recognized Northwest Hospital with,the 2008 Distinguished Hospital ...
... The State of Florida,has suddenly cut off ... skilled nursing care. Phillip Starling suffers from cerebral,palsy ... paralyzed left,side. He can only breathe with the ... in the right side of his body. His ...
... Mark your calendars for these,training and networking ... Detroit Chapter (IABC/Detroit)!, April 16 Luncheon Session: ... organization,s message impact its market,share? Find out when ... messaging has impacted today,s marketing landscape., Join ...
... and Preserve Buildings, NEW DELHI, India, April ... and Resources Institute (TERI) signed a memorandum of,understanding ... design and,certification in India., The agreement was ... Dr. R. K. Pachauri, director general, TERI, with ...
... April 8, 2008 Rising Medical ... containment organization, and,WorkCompEDI, an electronic transaction ... process electronic billing transactions,between healthcare Providers ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080206/AQW030LOGO-b ), ...
... Lierac Paris, Europe,s,celebrated anti-aging skincare line, continues its ... at CVS/pharmacy throughout the,Northeast., (Photo: ... are as follows: CVS/pharmacy Healthy Skincare Centers: ... Northeast U.S. (NY metro area, Boston, Washington, D.C.) ...
Cached Medicine News:Health News:Northwest Hospital & Medical Center Earns Distinguished Hospital Award for Patient Safety 2Health News:Northwest Hospital & Medical Center Earns Distinguished Hospital Award for Patient Safety 3Health News:Florida Abandons Paralyzed, Ventilator-Dependent 21-Year-Old Who Needs 24-Hour Skilled Nursing Care 2Health News:IABC/Detroit Announces April Professional Development and Networking Events 2Health News:DuPont and TERI Sign Memorandum of Understanding on Green Building Design in India 2Health News:DuPont and TERI Sign Memorandum of Understanding on Green Building Design in India 3Health News:DuPont and TERI Sign Memorandum of Understanding on Green Building Design in India 4Health News:Rising Medical Solutions and WorkCompEDI Establish Relationship to Provide Workers' Compensation eBilling Solutions 2Health News:Rising Medical Solutions and WorkCompEDI Establish Relationship to Provide Workers' Compensation eBilling Solutions 3Health News:Lierac Paris Expands in the United States at Healthy Skincare Centers at CVS/pharmacy 2Health News:Lierac Paris Expands in the United States at Healthy Skincare Centers at CVS/pharmacy 3
The double beveled oblique blade provides a true, straight incision. Penetrating through Bowman's and Descemet's membranes without inducing corneal distortion. No need to "Dimple Down"....
... The Boomerang ClosureWire Vascular Closure System ... Arteriotomy Site-Specific Compression., ,The Boomerang ClosureWire ... the inside of the arteriotomy and ... in a targeted internal compression of ...
... Lamp HSL150 with an adjustable slit image ... Veterinary medicine for the examination of the ... the new HEINE HSL 150,is the ideal ... not available,or practical to use.,With features such ...
... Geriatrics At Your Fingertips ... geriatrics that provides up-to-date, practical information on ... disorders most common to elderly people. Updated ... the GAYF web site, where versions for ...
Medicine Products: